MARKET

PRENW

PRENW

Artisan Acqu
NASDAQ
0.0289
-0.0009
-3.02%
Closed 09:30 01/07 EST
OPEN
0.0289
PREV CLOSE
0.0298
HIGH
0.0289
LOW
0.0289
VOLUME
120
TURNOVER
0
52 WEEK HIGH
0.0695
52 WEEK LOW
0.0077
MARKET CAP
--
P/E (TTM)
-0.0082
1D
5D
1M
3M
1Y
5Y
1D
Prenetics Sells Europa Sports Partners in $13 Million All-Stock Deal
Reuters · 1d ago
PRENETICS REINFORCES STRATEGIC FOCUS ON IM8, DIVESTS EUROPA BUSINESS FOR UP TO $13 MILLION
Reuters · 1d ago
Prenetics Global Reduces Dilution with 86.7% Participation in Warrant Exchange Program
Reuters · 2d ago
Weekly Report: what happened at PRENW last week (1229-0102)?
Weekly Report · 3d ago
Prenetics Global Ltd. Shifts Capital Allocation to Focus Exclusively on IM8 Brand Growth and Expansion, Ceases Further Bitcoin Purchases
Reuters · 12/30/2025 13:22
PRENETICS ANNOUNCES UPDATE TO CAPITAL ALLOCATION STRATEGY; CEASES BITCOIN PURCHASES TO FOCUS ON IM8
Reuters · 12/30/2025 13:00
Weekly Report: what happened at PRENW last week (1222-1226)?
Weekly Report · 12/29/2025 09:29
PRENETICS ENTERS INTO WARRANT EXCHANGE AGREEMENTS WITH WARRANT HOLDERS, STRENGTHENING CAPITAL STRUCTURE
Reuters · 12/23/2025 14:08
More
About PRENW
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.

Webull offers Prenetics Global Ltd stock information, including NASDAQ: PRENW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRENW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRENW stock methods without spending real money on the virtual paper trading platform.